News Mylan to develop Botox biosimilar with Revance Mylan takes aim at Allergan's off-patent blockbuster
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
